Search results
Results from the WOW.Com Content Network
Pravastatin, sold under the brand name Pravachol among others, is a statin medication, used for preventing cardiovascular disease in those at high risk and treating abnormal lipids. [5] It is suggested to be used together with diet changes, exercise, and weight loss. [ 5 ]
Injection site reactions (ISRs) are reactions that occur at the site of injection of a drug. They may be mild or severe and may or may not require medical intervention. Some reactions may appear immediately after injection, and some may be delayed. [1] Such reactions can occur with subcutaneous, intramuscular, or intravenous administration.
Da Costa's syndrome, also known as soldier's heart among other names, was a syndrome or a set of symptoms similar to those of heart disease.These include fatigue upon exertion, shortness of breath, palpitations, sweating, chest pain, and sometimes orthostatic intolerance.
Muscle pain (myalgia) is one of the most common side effects in patients right after starting statins, says Sameer Arora, MD, a cardiology fellow at the University of North Carolina at Chapel Hill ...
Unfortunately, the answer is quite broad—there are so many medical conditions that can cause pain in the chest. It can be as simple as a pulled muscle or as complicated as pulmonary embolism ...
Some gastroenterology conditions may be associated with costochondritis-like chest pain such as gastroesophageal reflux disease, and esophagitis. [22] Vitamin D deficiency can be a differential diagnosis for costochondritis as it may cause chest pain. [6] Chest pain has also been reported following the use of cocaine, which can increase the ...
It can cause a range of potential symptoms, including chest pain that can feel like pressure, tightness, pain, squeezing, or aching, as well as fatigue, nausea, and shortness of breath. A heart ...
The Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22 trial, also known as PROVE-IT TIMI 22, was a randomized, double-blind, clinical trial that recruited 4,162 people admitted within 10 days of an acute coronary event and randomised them to the lipid-lowering drugs pravastatin (40 mg) or atorvastatin (80 mg) and a 10-day course of the ...